Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220017989 220009212 1.76 97 null 2017-08-27 2017-10-15 Ipilimumab N N 220034678 RAVVA TRIAL
220017990 220009216 1.64 70.6 Palliative (P) null 2017-05-27 FIGARO TRIAL 2 N 220034686 TRASTUZUMAB
220017991 220009218 1.6 60.6 Curative (C) 2016-03-26 2016-03-30 CAPECITABINE + OXALIPLATIN 2 N 220034690 FCR
220017992 220014906 1.63 62 Curative (C) 2011-05-27 2013-07-25 CLADRIBINE 2 N 220034697 DABRAFENIB + TRAMETINIB
220017993 220009226 1.73 63.7 null 2014-10-01 2014-10-07 BUSULFAN + CYCLO 02 N 220034714 MACE
220017994 220009227 1.62 78.8 Curative (C) 2014-12-16 2015-02-08 Ipilimumab 2 N 220034715 PEMBROLIZUMAB
220017996 220009231 null null Curative (C) 2016-11-08 2016-11-09 Alemtuzumab+Busulfan+CyclophosphMUD 99 N 220034742 MYELOMA XI TRIAL
220017997 220009233 1.84 9.7 null 2013-11-20 2014-07-04 CHOP R - 21 days N N 220034750 MPT
220017998 220014913 0 95.4 Curative (C) 2018-03-01 2018-03-01 MITOXANTRONE + TRETINOIN 1 N 220034781 CETUXIMAB + IRINOTECAN + MDG
220017999 220009238 null 85 Curative (C) 2014-11-10 2014-11-10 Arsenic Triox + Tretinoin Ind W1-4 01 null 220034796 ARSENIC TRIOXIDE
220018000 220009241 1.4 47 Curative (C) 2018-01-09 2018-01-11 Capecitabine 01 N 220034798 PEMBROLIZUMAB
220018001 220009241 1.55 8.9 Curative (C) 2013-12-10 2013-12-16 IPILIMUMAB + NIVOLUMAB 01 N 220034798 LI-1 TRIAL
220018002 220014915 1.95 41.2 Palliative (P) null 2015-09-03 CLOFARABINE + DAUNORUBICIN null N 220034800 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220018003 220009244 null 78.4 Curative (C) 2015-03-05 2015-03-05 CLOFARABINE + CYCLO + CYTARABINE + ETOP N N 220034800 TRASTUZUMAB
220018004 220014917 1.72 75.6 Curative (C) 2014-07-17 2014-09-05 Cisplatin 7 day 02 N 220034818 TRASTUZUMAB
220018005 220009248 null 73 Curative (C) 2019-01-14 2019-01-18 Cyclophosphamide+Etopophos HD 02 null 220034830 METHOTREXATE HIGH DOSE
220018006 220009248 1.4 70.1 Curative (C) 2016-01-22 2016-02-28 Arsenic Triox + Tretinoin Ind W1-4 null null 220034830 TEMOZOLOMIDE
220018007 220009251 1.67 70.5 Curative (C) 2016-11-19 2016-12-09 Cetuximab 7 day (>Cycle 2) N N 220034845 MIDAC
220018008 220009254 1.65 9.4 null 2016-12-11 2016-12-12 Alemtuzumab+Busulfan+CyclophosphMUD N null 220034881 CYTARABINE IT + METHOTREXATE
220018009 220009255 1.57 60 Curative (C) 2017-09-08 2017-10-08 ALL UKALL2011 TRIAL 02 N 220034891 ARSENIC TRIOXIDE + ATRA
220018010 220009257 1.75 90 Curative (C) 2015-09-22 2015-09-22 MidAC 01 N 220034893 ETOPOSIDE
220018011 220018146 1.69 null Curative (C) 2013-10-15 2013-10-21 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN N N 220034910 CISPLATIN + RT
220018012 220009260 1.76 63 Curative (C) 2013-11-03 2014-04-07 Alemtuzumab + Cyclophos TBI Allo N Y 220034927 CYTARABINE + FLUDARABINE
220018013 220009262 1.65 89 Curative (C) 2016-10-19 2016-11-15 INTERFERON 02 N 220034933 CAPECITABINE + CARBOPLATIN
220018014 220009265 1.65 65.8 Curative (C) 2014-11-27 2014-12-10 Cyclophos + Dex + Lenalidomide N N 220034935 BUSULFAN + CYCLOPHOSPHAMIDE
220018015 220009268 1.62 80.7 Curative (C) 2017-07-03 2017-07-03 DABRAFENIB N N 220034947 VINCRISTINE
220018016 220021010 1.76 76 Disease modification (D) 2013-02-21 2013-06-09 Capecitabine N N 220035027 ARSENIC TRIOXIDE
220018017 220018149 1.7 76 Curative (C) 2017-06-02 2017-06-10 GEMCITABINE 01 N 220035062 BUSULPHAN
220018018 220009275 1.83 67.5 Curative (C) 2014-06-16 2014-07-28 MidAC 2 N 220035062 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220018019 220009277 null null Curative (C) 2016-07-24 2016-07-28 GEMCITABINE + OXALIPLATIN + PACLITAXEL null N 220035065 MYELOMA XI TRIAL
220018021 220009284 1.7 11.1 Curative (C) 2017-09-15 2017-10-27 CLOFARABINE + DAUNORUBICIN N N 220035089 UKALL 2003
220018025 220009294 1.56 null Curative (C) 2012-10-22 2014-03-04 LENALIDOMIDE N N 220035110 PEMBROLIZUMAB
220018026 220018155 1.56 78.3 Curative (C) null 2014-12-12 Cytarabine+Methotrexate Intrathecal N N 220035113 CYTARABINE + MITOXANTRONE
220018028 220014940 null 82 Curative (C) 2016-05-10 2016-05-18 IBRUTINIB null null 220035134 METHOTREXATE + PEGASPARGASE
220018029 220009300 1.73 82 null 2014-10-03 2017-02-25 Cisplatin + Radiotherapy N N 220035146 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220018030 220009304 1.68 72.5 Curative (C) 2017-10-07 2017-10-07 PEMBROLIZUMAB Y null 220035152 UKALL60+
220018031 220009306 null 74.4 Curative (C) 2016-09-23 2016-09-27 Enzalutamide N null 220035158 INTERFERON
220018032 220009308 1.64 125 null 2017-07-09 2017-07-10 AXITINIB N N 220035169 PEMETREXED
220018033 220009311 null null Curative (C) 2016-01-13 2016-01-15 Alemtuzumab+Busulfan+CyclophosphMUD 99 null 220035188 SORAFENIB
220018034 220009312 1.81 64.7 Curative (C) 2017-09-22 2017-09-25 Arsenic Trioxide (consolidation) N N 220035189 RAVVA TRIAL
220018035 220009317 1.64 62.2 Curative (C) 2015-08-29 2017-01-29 FIGARO TRIAL N N 220035190 ARSENIC TRIOXIDE + ATRA
220018037 220009321 1.73 67.1 Curative (C) 2015-06-13 2015-06-13 ALL UKALL2011 Std BFM Cons B Y N 220035200 FIGARO TRIAL
220018038 220009323 null null Curative (C) 2015-06-01 2015-06-18 BUSULFAN N N 220035212 CYTARABINE + FLUDARABINE + IDARUBICIN
220018039 220018158 1.66 -1 Curative (C) 2014-04-04 2014-04-08 FLUDARABINE N null 220035219 FLUDARABINE
220018040 220009326 1.79 83.7 Curative (C) 2018-01-14 2018-08-29 BUSULFAN + FLUDARABINE + METHOTREXATE 01 N 220035229 GCLAC
220018041 220009329 null 47 Curative (C) 2016-09-02 2017-08-09 PAC-E 01 N 220035232 BUSULFAN + CYCLOPHOSPHAMIDE
220018042 220009330 null 90 Curative (C) 2015-10-07 2015-10-16 BENDAMUSTINE + RITUXIMAB 99 N 220035241 FLUDARABINE
220018043 220009331 null 67.5 Curative (C) 2015-09-26 2015-09-29 VINCRISTINE N Y 220035243 MELPHALAN
220018044 220014953 -1 null Disease modification (D) null 2016-09-14 ALL UKALL60+ TRIAL N null 220035271 LENALIDOMIDE
220018045 220009336 null null Palliative (P) 2014-02-28 2014-03-04 Carboplatin + Cetux + FU (>Cycle 2) N N 220035279 ALEMTUZUMAB + CYCLOPHOSPHAMIDE